This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Gise, A.
Right arrow Articles by Troppmair, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Gise, A.
Right arrow Articles by Troppmair, J.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, April 2001, p. 2324-2336, Vol. 21, No. 7
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.7.2324-2336.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Apoptosis Suppression by Raf-1 and MEK1 Requires MEK- and Phosphatidylinositol 3-Kinase-Dependent Signals

Alexander von Gise,1 Petra Lorenz,1 Claudia Wellbrock,2 Brian Hemmings,3 Friederike Berberich-Siebelt,4 Ulf R. Rapp,1 and Jakob Troppmair1,*

Institut für Medizinische Strahlenkunde und Zellforschung,1 Department for Physiological Chemistry I, Biocenter (Theodor Boveri Institute),2 and Department of Molecular Pathology, Institute of Pathology,4 University of Würzburg, Würzburg, Germany, and Friedrich Miescher Institute, 4058 Basel, Switzerland3

Received 6 July 2000/Returned for modification 20 November 2000/Accepted 28 December 2000

Two Ras effector pathways leading to the activation of Raf-1 and phosphatidylinositol 3-kinase (PI3K) have been implicated in the survival signaling by the interleukin 3 (IL-3) receptor. Analysis of apoptosis suppression by Raf-1 demonstrated the requirement for mitochondrial translocation of the kinase in this process. This could be achieved either by overexpression of the antiapoptotic protein Bcl-2 or by targeting Raf-1 to the mitochondria via fusion to the mitochondrial protein Mas p70. Mitochondrially active Raf-1 is unable to activate extracellular signal-related kinase 1 (ERK1) and ERK2 but suppresses cell death by inactivating the proapoptotic Bcl-2 family member BAD. However, genetic and biochemical data also have suggested a role for the Raf-1 effector module MEK-ERK in apoptosis suppression. We thus tested for MEK requirement in cell survival signaling using the interleukin 3 (IL-3)-dependent cell line 32D. MEK is essential for survival and growth in the presence of IL-3. Upon growth factor withdrawal the expression of constitutively active MEK1 mutants significantly delays the onset of apoptosis, whereas the presence of a dominant negative mutant accelerates cell death. Survival signaling by MEK most likely results from the activation of ERKs since expression of a constitutively active form of ERK2 was as effective in protecting NIH 3T3 fibroblasts against doxorubicin-induced cell death as oncogenic MEK. The survival effect of activated MEK in 32D cells is achieved by both MEK- and PI3K-dependent mechanisms and results in the activation of PI3K and in the phosphorylation of AKT. MEK and PI3K dependence is also observed in 32D cells protected from apoptosis by oncogenic Raf-1. Additionally, we also could extend these findings to the IL-3-dependent pro-B-cell line BaF3, suggesting that recruitment of MEK is a common mechanism for survival signaling by activated Raf. Requirement for the PI3K effector AKT in this process is further demonstrated by the inhibitory effect of a dominant negative AKT mutant on Raf-1-induced cell survival. Moreover, a constitutively active form of AKT synergizes with Raf-1 in apoptosis suppression. In summary these data strongly suggest a Raf effector pathway for cell survival that is mediated by MEK and AKT.

* Corresponding author. Mailing address: Institut für Medizinische Strahlenkunde und Zellforschung (MSZ), University of Würzburg, Versbacher Str. 5, 97078 Würzburg, Germany. Phone: 49-931-201-3850. Fax: 49-931-201-3835. E-mail: troppmair{at}mail.uni-wuerzburg.de.

Molecular and Cellular Biology, April 2001, p. 2324-2336, Vol. 21, No. 7
0270-7306/01/$04.00+0   DOI: 10.1128/MCB.21.7.2324-2336.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Kuznetsov, A. V., Smigelskaite, J., Doblander, C., Janakiraman, M., Hermann, M., Wurm, M., Scheidl, S. F., Sucher, R., Deutschmann, A., Troppmair, J. (2008). Survival Signaling by C-RAF: Mitochondrial Reactive Oxygen Species and Ca2+ Are Critical Targets. Mol. Cell. Biol. 28: 2304-2313 [Abstract] [Full Text]  
  • Vasudevan, K. M., Burikhanov, R., Goswami, A., Rangnekar, V. M. (2007). Suppression of PTEN Expression Is Essential for Antiapoptosis and Cellular Transformation by Oncogenic Ras. Cancer Res. 67: 10343-10350 [Abstract] [Full Text]  
  • Veerapong, J., Bickenbach, K. A., Shao, M. Y., Smith, K. D., Posner, M. C., Roizman, B., Weichselbaum, R. R. (2007). Systemic Delivery of {gamma}134.5-Deleted Herpes Simplex Virus-1 Selectively Targets and Treats Distant Human Xenograft Tumors That Express High MEK Activity. Cancer Res. 67: 8301-8306 [Abstract] [Full Text]  
  • Kebache, S., Ash, J., Annis, M. G., Hagan, J., Huber, M., Hassard, J., Stewart, C. L., Whiteway, M., Nantel, A. (2007). Grb10 and Active Raf-1 Kinase Promote Bad-dependent Cell Survival. J. Biol. Chem. 282: 21873-21883 [Abstract] [Full Text]  
  • Ehrhardt, C., Wolff, T., Pleschka, S., Planz, O., Beermann, W., Bode, J. G., Schmolke, M., Ludwig, S. (2007). Influenza A Virus NS1 Protein Activates the PI3K/Akt Pathway To Mediate Antiapoptotic Signaling Responses. J. Virol. 81: 3058-3067 [Abstract] [Full Text]  
  • Sester, D. P., Brion, K., Trieu, A., Goodridge, H. S., Roberts, T. L., Dunn, J., Hume, D. A., Stacey, K. J., Sweet, M. J. (2006). CpG DNA Activates Survival in Murine Macrophages through TLR9 and the Phosphatidylinositol 3-Kinase-Akt Pathway. J. Immunol. 177: 4473-4480 [Abstract] [Full Text]  
  • Bissonauth, V., Roy, S., Gravel, M., Guillemette, S., Charron, J. (2006). Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis. Development 133: 3429-3440 [Abstract] [Full Text]  
  • Ekert, P. G., Jabbour, A. M., Manoharan, A., Heraud, J. E., Yu, J., Pakusch, M., Michalak, E. M., Kelly, P. N., Callus, B., Kiefer, T., Verhagen, A., Silke, J., Strasser, A., Borner, C., Vaux, D. L. (2006). Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood 108: 1461-1468 [Abstract] [Full Text]  
  • Kim, L., Denkers, E. Y. (2006). Toxoplasma gondii triggers Gi-dependent PI 3-kinase signaling required for inhibition of host cell apoptosis. J. Cell Sci. 119: 2119-2126 [Abstract] [Full Text]  
  • Smith, K. D., Mezhir, J. J., Bickenbach, K., Veerapong, J., Charron, J., Posner, M. C., Roizman, B., Weichselbaum, R. R. (2006). Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by {Delta}{gamma}134.5 Mutants of Herpes Simplex Virus 1. J. Virol. 80: 1110-1120 [Abstract] [Full Text]  
  • Konopleva, M., Shi, Y., Steelman, L. S., Shelton, J. G., Munsell, M., Marini, F., McQueen, T., Contractor, R., McCubrey, J. A., Andreeff, M. (2005). Development of a Conditional In vivo Model to Evaluate the Efficacy of Small Molecule Inhibitors for the Treatment of Raf-Transformed Hematopoietic Cells. Cancer Res. 65: 9962-9970 [Abstract] [Full Text]  
  • Mariappan, M. M., Senthil, D., Natarajan, K. S., Choudhury, G. G., Kasinath, B. S. (2005). Phospholipase C{gamma}-Erk Axis in Vascular Endothelial Growth Factor-induced Eukaryotic Initiation Factor 4E Phosphorylation and Protein Synthesis in Renal Epithelial Cells. J. Biol. Chem. 280: 28402-28411 [Abstract] [Full Text]  
  • Jin, S., Zhuo, Y., Guo, W., Field, J. (2005). p21-activated Kinase 1 (Pak1)-dependent Phosphorylation of Raf-1 Regulates Its Mitochondrial Localization, Phosphorylation of BAD, and Bcl-2 Association. J. Biol. Chem. 280: 24698-24705 [Abstract] [Full Text]  
  • Dai, Y., Rahmani, M., Pei, X.-Y., Khanna, P., Han, S. I., Mitchell, C., Dent, P., Grant, S. (2005). Farnesyltransferase inhibitors interact synergistically with the Chk1 inhibitor UCN-01 to induce apoptosis in human leukemia cells through interruption of both Akt and MEK/ERK pathways and activation of SEK1/JNK. Blood 105: 1706-1716 [Abstract] [Full Text]  
  • Hu, P., Han, Z., Couvillon, A. D., Exton, J. H. (2004). Critical Role of Endogenous Akt/IAPs and MEK1/ERK Pathways in Counteracting Endoplasmic Reticulum Stress-induced Cell Death. J. Biol. Chem. 279: 49420-49429 [Abstract] [Full Text]  
  • Hausenloy, D. J, Mocanu, M. M, Yellon, D. M (2004). Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. Cardiovasc Res 63: 305-312 [Abstract] [Full Text]  
  • Chung, C.-H., Wu, W.-B., Huang, T.-F. (2004). Aggretin, a snake venom-derived endothelial integrin {alpha}2{beta}1 agonist, induces angiogenesis via expression of vascular endothelial growth factor. Blood 103: 2105-2113 [Abstract] [Full Text]  
  • Bhattacharya, S., Ray, R. M., Johnson, L. R. (2004). Prevention of TNF-{alpha}-induced apoptosis in polyamine-depleted IEC-6 cells is mediated through the activation of ERK1/2. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G479-G490 [Abstract] [Full Text]  
  • Shibayama, H., Takai, E., Matsumura, I., Kouno, M., Morii, E., Kitamura, Y., Takeda, J., Kanakura, Y. (2004). Identification of a Cytokine-induced Antiapoptotic Molecule Anamorsin Essential for Definitive Hematopoiesis. JEM 199: 581-592 [Abstract] [Full Text]  
  • Karlsson, R., Engstrom, M., Jonsson, M., Karlberg, P., Pronk, C. J.H., Richter, J., Jonsson, J.-I. (2003). Phosphatidylinositol 3-kinase is essential for kit ligand-mediated survival, whereas interleukin-3 and flt3 ligand induce expression of antiapoptotic Bcl-2 family genes. J. Leukoc. Biol. 74: 923-931 [Abstract] [Full Text]  
  • Jia, W., Yu, C., Rahmani, M., Krystal, G., Sausville, E. A., Dent, P., Grant, S. (2003). Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways. Blood 102: 1824-1832 [Abstract] [Full Text]  
  • Alavi, A., Hood, J. D., Frausto, R., Stupack, D. G., Cheresh, D. A. (2003). Role of Raf in Vascular Protection from Distinct Apoptotic Stimuli. Science 301: 94-96 [Abstract] [Full Text]  
  • Bezombes, C., de Thonel, A., Apostolou, A., Louat, T., Jaffrezou, J.-P., Laurent, G., Quillet-Mary, A. (2002). Overexpression of Protein Kinase Czeta Confers Protection Against Antileukemic Drugs by Inhibiting the Redox-Dependent Sphingomyelinase Activation. Mol. Pharmacol. 62: 1446-1455 [Abstract] [Full Text]  
  • Fedorov, L. M., Tyrsin, O. Yu., Papadopoulos, T., Camarero, G., Gotz, R., Rapp, U. R. (2002). Bcl-2 Determines Susceptibility to Induction of Lung Cancer by Oncogenic CRaf. Cancer Res. 62: 6297-6303 [Abstract] [Full Text]  
  • Gokhale, P. C., Zhang, C., Newsome, J. T., Pei, J., Ahmad, I., Rahman, A., Dritschilo, A., Kasid, U. N. (2002). Pharmacokinetics, Toxicity, and Efficacy of Ends-modified raf Antisense Oligodeoxyribonucleotide Encapsulated in a Novel Cationic Liposome. Clin. Cancer Res. 8: 3611-3621 [Abstract] [Full Text]  
  • Tong, Z., Singh, G., Rainbow, A. J. (2002). Sustained Activation of the Extracellular Signal-regulated Kinase Pathway Protects Cells from Photofrin-mediated Photodynamic Therapy. Cancer Res. 62: 5528-5535 [Abstract] [Full Text]  
  • Moelling, K., Schad, K., Bosse, M., Zimmermann, S., Schweneker, M. (2002). Regulation of Raf-Akt Cross-talk. J. Biol. Chem. 277: 31099-31106 [Abstract] [Full Text]  
  • Hindley, A., Kolch, W. (2002). Extracellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK)-independent functions of Raf kinases. J. Cell Sci. 115: 1575-1581 [Abstract] [Full Text]  
  • Wolfman, J. C., Palmby, T., Der, C. J., Wolfman, A. (2002). Cellular N-Ras Promotes Cell Survival by Downregulation of Jun N-Terminal Protein Kinase and p38. Mol. Cell. Biol. 22: 1589-1606 [Abstract] [Full Text]  
  • Wellbrock, C., Weisser, C., Geissinger, E., Troppmair, J., Schartl, M. (2002). Activation of p59Fyn Leads to Melanocyte Dedifferentiation by Influencing MKP-1-regulated Mitogen-activated Protein Kinase Signaling. J. Biol. Chem. 277: 6443-6454 [Abstract] [Full Text]  
  • Tognon, C., Garnett, M., Kenward, E., Kay, R., Morrison, K., Sorensen, P. H. B. (2001). The Chimeric Protein Tyrosine Kinase ETV6-NTRK3 Requires both Ras-Erk1/2 and PI3-Kinase-Akt Signaling for Fibroblast Transformation. Cancer Res. 61: 8909-8916 [Abstract] [Full Text]  
  • Jordan, B. W. M., Dinev, D., LeMellay, V., Troppmair, J., Gotz, R., Wixler, L., Sendtner, M., Ludwig, S., Rapp, U. R. (2001). Neurotrophin Receptor-interacting Mage Homologue Is an Inducible Inhibitor of Apoptosis Protein-interacting Protein That Augments Cell Death. J. Biol. Chem. 276: 39985-39989 [Abstract] [Full Text]  
  • Zhou, J.-H., Broussard, S. R., Strle, K., Freund, G. G., Johnson, R. W., Dantzer, R., Kelley, K. W. (2001). IL-10 Inhibits Apoptosis of Promyeloid Cells by Activating Insulin Receptor Substrate-2 and Phosphatidylinositol 3'-Kinase. J. Immunol. 167: 4436-4442 [Abstract] [Full Text]  
  • Murakami, M. S., Morrison, D. K. (2001). Raf-1 Without MEK?. Sci Signal 2001: pe30-pe30 [Abstract] [Full Text]  
  • Craig, R., Wagner, M., McCardle, T., Craig, A. G., Glembotski, C. C. (2001). The Cytoprotective Effects of the Glycoprotein 130 Receptor-coupled Cytokine, Cardiotrophin-1, Require Activation of NF-kappa B. J. Biol. Chem. 276: 37621-37629 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»